Centene Corporation (CNC)
$
33.32
-0.47 (-1.41%)
Key metrics
Financial statements
Free cash flow per share
3.0068
Market cap
26.9 Billion
Price to sales ratio
0.1587
Debt to equity
0.6563
Current ratio
1.1116
Income quality
0.6154
Average inventory
0
ROE
0.1267
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government-subsidized programs, including Medicaid, the State Children's Health Insurance Program, long-term services and support, foster care, and Medicare-Medicaid plans that cover dually eligible individuals, as well as aged, blind, or disabled programs. The financial data pertains to the fiscal year 2024 with a diluted EPS of $6.31 accounting for potential share dilution. The operating expenses amount to $31,460,000,000.00 encompassing various operational costs incurred by the company. The income before tax ratio is 0.03 reflecting the pre-tax margin and indicating a comprehensive financial overview. Furthermore, the EBITDA ratio is 0.03 highlighting the company's operational efficiency across its diverse offerings. Its health plans include primary
Investing in Centene Corporation (CNC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Centene Corporation stock to fluctuate between $33.30 (low) and $80.59 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-07-03, Centene Corporation's market cap is $16,577,643,945, based on 497,603,000 outstanding shares.
Compared to Eli Lilly & Co., Centene Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy Centene Corporation (CNC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CNC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Centene Corporation's last stock split was 2:1 on 2019-02-07.
Revenue: $163,071,000,000 | EPS: $6.33 | Growth: 27.36%.
Visit https://www.centene.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $98.53 (2022-08-15) | All-time low: $33.30 (2025-07-03).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
SAN FRANCISCO, July 03, 2025 (GLOBE NEWSWIRE) -- On July 2, 2025, investors in Centene Corp. (NYSE: CNC) saw the price of their shares of this normally low-volatility stock crash 40%, after the company withdrew its guidance, blaming preliminary discussions and data generated by an independent actuary, Wakely.
seekingalpha.com
Centene's 40% drop after pulling 2025 guidance is driven by rising medical costs and margin pressure, but the sell-off appears overdone. Historical patterns show that similar sell-offs in 2016 and 2020 were followed by recoveries as premiums were adjusted upward. Valuation is now highly attractive, with Price/Cash Flow below 8, making CNC stock a compelling buy despite sector volatility.
youtube.com
'Mad Money' host Jim Cramer dissects Centene's massive plummet following earnings.
youtube.com
'Mad Money' host Jim Cramer dissects Centene's massive plummet following earnings.
investopedia.com
Major U.S. equities indexes finished Wednesday mixed as President Donald Trump announced that the U.S. has reached a trade deal with Vietnam.
seekingalpha.com
Centene's stock plunged after slashing 2025 EPS guidance due to higher-than-expected morbidity and lower market growth in key states. The company's previous bullish guidance failed to materialize. Despite the sharp drop, Centene trades at historically low price-to-sales multiples and investment grade status, making valuation attractive for risk-tolerant investors.
businesswire.com
LOS ANGELES--(BUSINESS WIRE)---- $CNC--CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm.
businesswire.com
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CENTENE CORPORATION (CNC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 1, 2025, Centene announced that it was withdrawing its previo.
proactiveinvestors.com
Centene Corp (NYSE:CNC) shares fell almost 40% after the healthcare company withdrew its full-year 2025 financial guidance due to weak growth and higher-than-expected costs in its Affordable Care Act (ACA) marketplace business. Based on a preliminary analysis from the independent actuarial firm Wakely, Centene anticipates a $1.8 billion shortfall in risk adjustment revenue for 2025, which translates to a $2.75 per share reduction in adjusted earnings.
zacks.com
CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.
See all news